在经典的临床病理学评分 (PREDICT 2.1,INFLUENCE 2.0,CTS5) 上,RSClin是否提供了额外的信息?
Ana-Alicia Beltran-Bless1, Gregory R Pond2, Jane Bayani3
1Division of Medical Oncology, Department of Medicine, The University of Ottawa, Ottawa, Canada.
Breast (Edinburgh, Scotland)
|July 9, 2025
概括
将基因表达概况与临床病理因素相结合,可以改善乳腺癌的早期预后. 与其他风险计算器和基因表达试验相比,RSClin工具在N0患者中表现出更好的预后能力.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物统计学 生物统计学
背景情况:
- 早期乳腺癌 (EBC) 管理受益于准确的预后工具.
- 基因表达概况 (例如,瘤型-Dx) 和临床病理风险计算器 (例如,PREDICT 2.1,INFLUENCE 2.0,CTS5) 用于风险分层.
- 结合分子和临床病理数据的工具 (例如RSClin) 可能提供更好的预后信息.
研究的目的:
- 为了比较基因表达造型测试的预后性能与临床病理风险计算器和经更年期妇女的结合工具.
- 评估不同风险评估工具预测远程转移无生存率 (DMFS) 的能力.
主要方法:
- 分析TEAM病理队列,包括4736名经期绝经后的女性,她们接受了内分泌疗法治疗.
- 通过基因表达概况生成型Dx训练的风险得分.
- 使用PREDICT 2.1,INFLUENCE 2.0,CTS5和RSClin. 的方法计算复发率得分.
- 使用考克斯回归和哈雷尔的C统计在N0/N1人群中评估的预测能力.
主要成果:
- 在临床病理学计算器 (PREDICT 2.1,INFLUENCE 2.0,CTS5) 和经过Oncotype-Dx训练的风险得分之间观察到较低的相关性.
- 在N0名患者中,RSClin表现出与PREDICT 2.1 (0.60),INFLUENCE 2.0 (0.57),CTS-5 (0.62) 和Oncotype-Dx (0.63) 相比,RSClin对DMFS的预后能力优越 (C-统计值=0.66).
结论:
- 结合分子 (基因表达) 和临床病理因素,显著提高了早期乳腺癌的预后信息.
- 像RSClin这样的组合工具的临床实用性需要对患者管理决策进行进一步的前性验证.
相关概念视频
Receiver Operating Characteristic Plot
337
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
337
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
127
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
127
Comparing the Survival Analysis of Two or More Groups
297
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
297
Sensitivity, Specificity, and Predicted Value
677
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
677
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
180
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
180
Multiple Comparison Tests
4.0K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.0K


